Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Endothelial Glycocalyx and Vascular Function in Patients With Type 2 Diabetes and Albuminuria After Administration of Dulaglutide and Dapagliflozin vs DPP-4 Inhibitors

NCT06611904 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT06611904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Endothelial Glycocalyx and Vascular Function in Patients With Type 2 Diabetes and Albuminuria After Administration of Dulaglutide and Dapagliflozin vs DPP-4 Inhibitors
Lead sponsor
Attikon Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2018
Completion date
December 15, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, glycocalyx, urine albumin (ualb)